We envision a future where genomic data becomes ubiquitous, with its insights for enhancing healthcare securely available and accessible to all. Shivom is pioneering the omics ecosystem to make this vision a reality by offering a first-of-its-kind investment proposition in the rapidly growing market for personalized medicine, powered by state-of-the-art blockchain technology.
We will additionally build a state-of-the art and not-for-profit drug discovery and precision medicine organization. Shivom researchers will use data-driven tools and techniques, particularly machine learning methods that underpin artificial intelligence, which will offer promise in improving healthcare systems and services around the globe.
Blockchain technology is our tech partner of choice because it is able to address trust issues, including patient consent, data ownership, data integrity, and authentication. Blockchain can also manage complex data rights and allow finegrained access using smart contracts.
With SHIVOM everybody will be able to get their genome sequenced and stored, and our ecosystem will ofer an open web-marketplace for other providers to add their apps and services, alongside genomic data analytics and personalized medicine. Solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.
Ethereum ERC20 standard token.
Q4 2018/Q1 2019
Attention. There is a risk that unverified members are not actually members of the team
$43 000 000
$46 838 890
SHIVOM is a decentralized block chain platform where people can get their genome sequenced and stored hence enabling the establishment of a highly scalable and fully integrated health care vertical.
24-Apr: I have no plans to participate in Project Shivom.
Judging from the negative point I have raised, the project does not sound of investment quality. However, the overall concept of the platform is unique, and the venture could face a revisit if the inefficiencies get the adequate solutions. In conclusion for this stage, there is not enough information regarding the Shivom project. There is little information on the part of their operations and supposed partnerships or advisors. As such, I would not recommend on putting your investment in such a project.
Strengths: signed partnerships; very strong team and world-renowned advisors. Thorough market research and clear vision of the market, business model is presented in detailed way. Weaknesses: no financial plan/projection, no competitor analysis, no marketing plan. The product is technically advanced, this may require additional funds.
This offer is based on information provided solely by the offeror and other publicly available information. The token sale or exchange event is entirely unrelated to ICOholder and ICOholder has no involvement in it (including any technical support or promotion). Token sales listed from persons that ICOholder has no relationship with are shown only to help customers keep track of the activity taking place within the overall token sector. This information is not intended to amount to advice on which you should rely. You must obtain professional or specialist advice or carry out your own due diligence before taking, or refraining from, any action on the basis of the content on our site. Any terms and conditions entered into by contributors in respect of the acquisition of Tokens are between them and the issuer of the Token and ICOholder is not the seller of such Tokens. ICOholder has no legal responsibility for any representations made by third parties in respect of any Token sale and any claim for breach of contract must also be made directly against the Token issuing entity listed herein.
If you have any concerns about the nature, propriety or legality of this token sale or the persons involved in it please contact [email protected] with detailed information about your concerns.